3.49
price up icon1.75%   0.06
after-market Handel nachbörslich: 3.43 -0.06 -1.72%
loading

Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
49.89%
69.81
46.57 40.78 35.23 41.57
Depreciation and Amortization
0.00%
0.104
0.104 0.104 0.104 0.104
Operating Income/Loss
49.89%
-69.81
-46.57 -40.78 -35.23 -41.57
Income/Loss From Continuing Operations Before Tax
62.15%
-62.94
-38.81 -32.92 -27.93 -35.27
Income Tax Expense/Benefit
33.81%
0.231
0.349 0.221 0.251 0.197
Income/Loss From Continuing Operations After Tax
61.29%
-63.17
-39.16 -33.14 -28.18 -35.47
Net Income/Loss
61.29%
-63.17
-39.16 -33.14 -28.18 -35.47
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
544.03K%
83.92
0.0154 83.40 83.40 83.33
Diluted Average Shares
544.03K%
83.92
0.0154 83.40 83.40 83.33
Basic Earnings Per Share
59.57%
-0.75
-0.47 -0.40 -0.34 -0.43
Diluted Earnings Per Share
59.57%
-0.75
-0.47 -0.40 -0.34 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):